CONMED Corporation

NYSE:CNMD

Medical - Devices

Healthcare
$48.01 +0.75%

+$0.24 today

Market cap
$1.43B
Beta
0.92
P/E (TTM)
18.0
EPS (TTM)
$1.79
Dividend yield
1.24%
52W Low $31.84High $56.64

Volume 0.36M

Average 0.45M

CNMD Pre-Tax Margin

Income before tax as a percentage of revenue.

CONMED CorporationNYSE: CNMD

Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026

Pre-tax margin widens to 5.8%

Pre-tax margin was 5.8% in Q1 FY2026, up 3.4 pp from a year earlier. On a trailing-twelve-month basis it was 6.0%, down 5.1 pp year over year. Over 3 fiscal years it widened by 12.0 pp.

Context

  • Pre-tax margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
5.8%-2.0 pp QoQ
Last fiscal yearDec 2025
5.2%-7.3 pp YoY
LTMMar 2026
6.0%-5.1 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+3.4 pp——
1 year-7.3 pp——
3 years+12.0 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
5.2%
Year-over-year change
-7.3pp

Pre-Tax Margin vs competitors

How CNMD compares with its peers on the latest reported figures

  • CNMD's LTM Mar 2026 pre-tax margin of 6.0% is the 3rd highest of the 11 companies compared; the peer median is -15.0%.
  • Its year-over-year change of -5.1 pp is the 6th highest of 11, against a peer median of -2.5 pp.
  • Over three fiscal years its change of +12.0 pp compares with a peer median of -1.2 pp.
CNMD Competitors Peer median
Pre-Tax Margin for CNMD and competitors
Company Period LTM level YoY 3-year change
INMDInMode Ltd.LTM Mar 202627.3% -8.4 pp-14.6 pp
UFPTUFP Technologies, Inc.LTM Jun 202614.0% +0.1 pp-1.2 pp
CNMDCONMED CorporationLTM Mar 20266.0% -5.1 pp+12.0 pp
AHCOAdaptHealth Corp.LTM Apr 2026-1.0% -5.8 pp-3.8 pp
NEOGNeogen CorporationLTM Aug 2026-7.7% +113.4 pp+1.6 pp
SSIISS Innovations International, Inc.LTM Mar 2026-12.2% +86.7 pp+364.9 pp
ESTAEstablishment Labs Holdings Inc.LTM Sep 2026-17.7% +25.2 pp+17.5 pp
AZTAAzenta, Inc.LTM Sep 2026-24.3% -23.6 pp-19.7 pp
NVCRNovoCure LimitedLTM Mar 2026-26.0% -5.1 pp-5.6 pp
KMTSKestra Medical Technologies, Ltd.LTM Jan 2026-171.6% -10.2 pp—
NTLAIntellia Therapeutics, Inc.LTM Mar 2026-597.0% +557.1 pp+299.9 pp
Peer median (excluding CNMD) -15.0%-2.5 pp-1.2 pp

Competitors are the stored peer set for CNMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.01B1.05B1.24B1.31B1.37B
Cost of Revenue442.6M474.23M568.5M573.98M649.12M
Gross Profit568.04M571.25M676.25M733.03M725.38M
Gross Margin56.2%54.6%54.3%56.1%52.8%
Research & Development43.57M47.15M52.6M54.43M55.88M
Selling, General & Admin414.75M454.04M503.04M478.28M528.36M
Operating Expenses458.32M501.19M555.64M532.71M584.24M
Depreciation & Amortization70.74M49.76M71.87M71.86M52.34M
EBITDA179.33M7.8M192.48M272.18M154.55M
EBITDA Margin17.7%0.7%15.5%20.8%11.2%
Operating Income109.72M70.05M120.6M200.33M141.13M
Operating Margin10.9%6.7%9.7%15.3%10.3%
Interest Income00000
Interest Expense35.49M28.91M39.78M37.3M31.09M
Other Income / Expenses(36.61M)(140.92M)(39.78M)(37.3M)(70.01M)
Income Before Tax73.11M(70.86M)80.83M163.03M71.12M
Pre-Tax Margin7.2%-6.8%6.5%12.5%5.2%
Income Tax Expense10.56M9.72M16.37M30.61M24.06M
Net Income62.54M(80.58M)64.46M132.42M47.06M
Net Margin6.2%-7.7%5.2%10.1%3.4%
EPS (Basic)2.14(2.68)2.104.291.52
EPS (Diluted)1.94(2.68)2.044.261.51
Weighted Avg Shares29.16M30.04M30.67M30.85M31.04M
Weighted Avg Shares (Diluted)32.22M30.04M31.55M31.11M31.15M

CONMED Corporation

NYSE:CNMD

Intrinsic Alpha fair value

Locked

Current Price

$48.01

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.